| Product NDC: | 46129-200 |
| Proprietary Name: | Antizol |
| Non Proprietary Name: | fomepizole |
| Active Ingredient(s): | 1 g/mL & nbsp; fomepizole |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 46129-200 |
| Labeler Name: | PALADIN LABORATORIES (USA) INC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020696 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090731 |
| Package NDC: | 46129-200-02 |
| Package Description: | 4 VIAL in 1 PACKAGE (46129-200-02) > 1.5 mL in 1 VIAL |
| NDC Code | 46129-200-02 |
| Proprietary Name | Antizol |
| Package Description | 4 VIAL in 1 PACKAGE (46129-200-02) > 1.5 mL in 1 VIAL |
| Product NDC | 46129-200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fomepizole |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090731 |
| Marketing Category Name | NDA |
| Labeler Name | PALADIN LABORATORIES (USA) INC |
| Substance Name | FOMEPIZOLE |
| Strength Number | 1 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Antidote [EPC] |